At 3 years, Agent still outshined uncoated balloons. Registry data show rapid uptake of the DCB in the year after its FDA approval.
WASHINGTON, DC—A newly approved drug-coated balloon (DCB) for the treatment of in-stent restenosis (ISR) continues to be safe and effective, with fewer events and repeat interventions compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results